>
Switch to:

Ionis Pharmaceuticals Net Income From Continuing Operations

: $-486.8 Mil (TTM As of Dec. 2020)
View and export this data going back to 1991. Start your Free Trial

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Ionis Pharmaceuticals's net income from continuing operations for the three months ended in Dec. 2020 was $-341.4 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2020 was $-486.8 Mil.

Ionis Pharmaceuticals Net Income From Continuing Operations Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Ionis Pharmaceuticals Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Net Income From Continuing Operations Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -60.40 -10.78 214.99 303.26 -486.77

Ionis Pharmaceuticals Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Net Income From Continuing Operations Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 203.96 -58.48 -43.77 -43.09 -341.43

Ionis Pharmaceuticals Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2020 was -58.48 (Mar. 2020 ) + -43.769 (Jun. 2020 ) + -43.091 (Sep. 2020 ) + -341.426 (Dec. 2020 ) = $-486.8 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Ionis Pharmaceuticals Net Income From Continuing Operations Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)